JP2017519023A5 - - Google Patents

Download PDF

Info

Publication number
JP2017519023A5
JP2017519023A5 JP2016574907A JP2016574907A JP2017519023A5 JP 2017519023 A5 JP2017519023 A5 JP 2017519023A5 JP 2016574907 A JP2016574907 A JP 2016574907A JP 2016574907 A JP2016574907 A JP 2016574907A JP 2017519023 A5 JP2017519023 A5 JP 2017519023A5
Authority
JP
Japan
Prior art keywords
pyrrolo
amine
pyrimidin
benzenesulfonyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016574907A
Other languages
English (en)
Japanese (ja)
Other versions
JP6574450B2 (ja
JP2017519023A (ja
Filing date
Publication date
Priority claimed from GBGB1411236.1A external-priority patent/GB201411236D0/en
Application filed filed Critical
Publication of JP2017519023A publication Critical patent/JP2017519023A/ja
Publication of JP2017519023A5 publication Critical patent/JP2017519023A5/ja
Application granted granted Critical
Publication of JP6574450B2 publication Critical patent/JP6574450B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016574907A 2014-06-25 2015-06-24 3−置換2−アミノ−インドール誘導体 Expired - Fee Related JP6574450B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1411236.1A GB201411236D0 (en) 2014-06-25 2014-06-25 Novel compounds
GB1411236.1 2014-06-25
PCT/GB2015/051840 WO2015198045A1 (en) 2014-06-25 2015-06-24 3-substituted 2-amino-indole derivatives

Publications (3)

Publication Number Publication Date
JP2017519023A JP2017519023A (ja) 2017-07-13
JP2017519023A5 true JP2017519023A5 (enExample) 2018-08-02
JP6574450B2 JP6574450B2 (ja) 2019-09-11

Family

ID=51410054

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016574907A Expired - Fee Related JP6574450B2 (ja) 2014-06-25 2015-06-24 3−置換2−アミノ−インドール誘導体

Country Status (7)

Country Link
US (1) US10059713B2 (enExample)
EP (1) EP3160965A1 (enExample)
JP (1) JP6574450B2 (enExample)
CN (1) CN106488919B (enExample)
CA (1) CA2952339A1 (enExample)
GB (1) GB201411236D0 (enExample)
WO (1) WO2015198045A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2021006804A (es) 2015-12-17 2023-01-13 Merck Patent Gmbh Antagonistas policiclicos del receptor 7/8 tipo toll (tlr7/8) y uso de los mismos en el tratamiento de trastornos inmunitarios.
EP4198031A1 (en) 2016-08-08 2023-06-21 Merck Patent GmbH Tlr7/8 antagonists and uses thereof
BR102018007822A2 (pt) 2017-04-20 2018-11-06 Gilead Sciences, Inc. composto, métodos para inibir pd-1, pd-l1 e/ou interação de pd-1/pd-l1 e para tratamento de câncer, composição farmacêutica, e, kit para tratamento de ou prevenção de câncer ou uma doença ou condição
KR102708681B1 (ko) 2018-02-13 2024-09-26 길리애드 사이언시즈, 인코포레이티드 Pd-1/pd-l1 억제제
CN108440496B (zh) * 2018-03-01 2019-09-10 苏州大学 一种制备2-氨基吲哚衍生物的方法
MD3762368T2 (ro) 2018-03-08 2022-07-31 Incyte Corp Compuși diol aminopirazină ca inhibitori ai PI3K-Y
EP4600247A3 (en) 2018-04-19 2025-11-19 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors
UA126421C2 (uk) 2018-07-13 2022-09-28 Гіліад Сайєнсіз, Інк. Інгібітори pd-1/pd-l1
US11236085B2 (en) 2018-10-24 2022-02-01 Gilead Sciences, Inc. PD-1/PD-L1 inhibitors
WO2021115286A1 (zh) * 2019-12-10 2021-06-17 成都倍特药业股份有限公司 一种可用作shp2抑制剂的含氮杂原子的六元并五元芳环衍生物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187777B1 (en) * 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
TW200306191A (en) * 2002-02-22 2003-11-16 Teijin Ltd Pyrrolopyrimidine derivatives
US20040122218A1 (en) * 2002-12-20 2004-06-24 Sean Turner Pyrrolopyridine potassium channel openers
WO2005023818A2 (en) 2003-09-10 2005-03-17 Gpc Biotech Ag Heterobicyclic compounds as pharmaceutically active agents
CA2797281A1 (en) * 2010-05-06 2011-11-10 Merck Sharp & Dohme Corp. Aza-indole derivatives useful as modulators of faah
WO2011153553A2 (en) * 2010-06-04 2011-12-08 The Regents Of The University Of California Methods and compositions for kinase inhibition
WO2012064898A1 (en) * 2010-11-09 2012-05-18 Yuan Chen Singleton inhibitors of sumoylation enzymes and methods for their use
WO2014011911A2 (en) 2012-07-11 2014-01-16 Nimbus Iris, Inc. Irak inhibitors and uses thereof

Similar Documents

Publication Publication Date Title
JP2023071767A (ja) Brm標的化化合物および関連使用方法
EP3515916B1 (en) Shp2 phosphatase inhibitors and methods of use thereof
EP3468972B1 (en) Compounds and compositions for inhibiting the activity of shp2
US10287266B2 (en) Compounds and compositions for inhibiting the activity of SHP2
JP6736559B2 (ja) トリアゾロピリミジン化合物およびその使用
US10966980B2 (en) Pyrrolo[2,3-d]pyrimidine derivatives
DK3183247T3 (en) Aminopyrimidinyl compounds as JAK inhibitors
US20200181168A1 (en) N-azaspirocycloalkane substituted n-heteroaryl compounds and compositions for inhibiting the activity of shp2
AU2018233402A1 (en) Pyrimidinyl-pyridyloxy-naphthyl compounds and methods of treating ire1-related diseases and disorders
RU2018115722A (ru) N-СУЛЬФОНИЛИРОВАННЫЕ ПИРАЗОЛО[3,4-b]ПИРИДИН-6-КАРБОКСАМИДЫ И СПОСОБ ИХ ПРИМЕНЕНИЯ
RU2019115115A (ru) Производные пиперидина в качестве ингибиторов убиквитин-специфической протеазы 7
KR20240018446A (ko) 돌연변이 braf의 분해를 위한 요법
EP3310771A1 (en) Compounds and compositions for inhibiting the activity of shp2
JP2017525757A5 (enExample)
JP2013523884A5 (enExample)
EP4631948A1 (en) Novel tricyclic compound as kras g12d inhibitor, and use thereof
CN105209460A (zh) 作为突变idh抑制剂的3-嘧啶-4-基-噁唑烷-2-酮化合物
JP2014528951A (ja) 変異体idhの阻害剤としての3−ピリミジン−4−イル−オキサゾリジン−2−オン類
JP7763753B2 (ja) アザキノリン化合物およびその使用
JP2019522049A (ja) トリアゾロピリジン化合物及びその使用
NZ728122A (en) 6,7-dihydropyrazolo[1,5-a]pyrazin-4(5h)-one compounds and their use as negative allosteric modulators of mglur2 receptors
US10577362B2 (en) Substituted 2, 4-diamino-quinoline derivatives for use in the treatment of proliferative diseases
JP2017531672A5 (enExample)
CN112154145A (zh) 哌嗪氮杂螺衍生物
RU2007130153A (ru) Амидные производные